| NOREPINEPHRINE BITARTRATE |
214455 |
001 |
ANDA |
NOREPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
EQ 1MG BASE/ML |
No
|
No
|
2021/01/22
|
2021/01/22
|
BRECKENRIDGE |
Prescription |
| NOREPINEPHRINE BITARTRATE |
211980 |
001 |
ANDA |
NOREPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
EQ 1MG BASE/ML |
No
|
No
|
2021/01/29
|
2021/01/29
|
SUN PHARM |
Discontinued |
| EPINEPHRINE |
208908 |
001 |
ANDA |
EPINEPHRINE |
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
EQ 1MG BASE/ML (EQ 1MG BASE/ML) |
No
|
No
|
2021/03/17
(TA)
|
--
|
HOSPIRA INC |
None (Tentative Approval) |
| NOREPINEPHRINE BITARTRATE |
214323 |
001 |
ANDA |
NOREPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
EQ 1MG BASE/ML |
No
|
No
|
2021/05/06
|
2021/05/06
|
GLAND PHARMA LTD |
Prescription |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
208475 |
001 |
ANDA |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.005MG/ML;1.5% |
No
|
No
|
2021/09/08
|
2021/09/08
|
B BRAUN MEDICAL INC |
Prescription |
| NOREPINEPHRINE BITARTRATE |
216341 |
001 |
ANDA |
NOREPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
EQ 1MG BASE/ML |
No
|
No
|
2022/07/19
|
2022/07/19
|
ZYDUS PHARMS |
Discontinued |
| EPINEPHRINE |
211363 |
001 |
NDA |
EPINEPHRINE |
SOLUTION;INTRAVENOUS |
1MG/10ML (0.1MG/ML) |
Yes
|
Yes
|
2022/08/15
|
2022/08/15
|
INTL MEDICATION SYS |
Prescription |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE |
215700 |
001 |
NDA |
NOREPINEPHRINE BITARTRATE |
SOLUTION;INTRAVENOUS |
EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) |
Yes
|
Yes
|
2022/09/15
|
2022/09/15
|
INFORLIFE |
Prescription |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE |
215700 |
002 |
NDA |
NOREPINEPHRINE BITARTRATE |
SOLUTION;INTRAVENOUS |
EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) |
Yes
|
Yes
|
2022/09/15
|
2022/09/15
|
INFORLIFE |
Prescription |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE |
215700 |
003 |
NDA |
NOREPINEPHRINE BITARTRATE |
SOLUTION;INTRAVENOUS |
EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) |
Yes
|
Yes
|
2022/09/15
|
2022/09/15
|
INFORLIFE |
Prescription |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE |
214628 |
001 |
NDA |
NOREPINEPHRINE BITARTRATE |
SOLUTION;INTRAVENOUS |
EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML) |
Yes
|
Yes
|
2022/10/06
|
2022/10/06
|
LONG GROVE PHARMS |
Prescription |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE |
214628 |
002 |
NDA |
NOREPINEPHRINE BITARTRATE |
SOLUTION;INTRAVENOUS |
EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) |
Yes
|
Yes
|
2022/10/06
|
2022/10/06
|
LONG GROVE PHARMS |
Prescription |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE |
214628 |
003 |
NDA |
NOREPINEPHRINE BITARTRATE |
SOLUTION;INTRAVENOUS |
EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) |
Yes
|
Yes
|
2022/10/06
|
2022/10/06
|
LONG GROVE PHARMS |
Prescription |
| NOREPINEPHRINE BITARTRATE |
217575 |
001 |
ANDA |
NOREPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
EQ 1MG BASE/ML |
No
|
No
|
2023/09/15
|
2023/09/15
|
CAPLIN |
Prescription |
| NOREPINEPHRINE BITARTRATE |
218758 |
001 |
ANDA |
NOREPINEPHRINE BITARTRATE |
INJECTABLE;INJECTION |
EQ 1MG BASE/ML |
No
|
No
|
2024/05/13
|
2024/05/13
|
RISING |
Prescription |
| EPINEPHRINE |
217192 |
001 |
ANDA |
EPINEPHRINE |
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
EQ 30MG BASE/30ML (EQ 1MG BASE/ML) |
No
|
No
|
2024/09/06
|
2024/09/06
|
AM REGENT |
Prescription |
| EPINEPHRINE |
215425 |
001 |
NDA |
EPINEPHRINE |
INJECTABLE;INJECTION |
30MG/30ML(1MG/ML) |
No
|
No
|
2024/10/30
(TA)
|
--
|
FRESENIUS KABI USA |
None (Tentative Approval) |
| EPINEPHRINE |
213708 |
001 |
ANDA |
EPINEPHRINE |
SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS |
1MG/ML (1MG/ML) |
No
|
No
|
2024/11/20
|
2024/11/20
|
FRESENIUS KABI USA |
Prescription |